Dental Care Clinics in Grosse Ile, MI Accepting Medicare
4 Dental Care Clinics found. Showing 1 - 4
 Lifelong Family Dentistry Pllc Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 8930 Macomb St, Grosse Ile, MI 48138 Phone: 734-676-2288 |
Beverly T Morris Dds Pc Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 24201 Meridian Rd, Grosse Ile, MI 48138 Phone: 734-692-0102 Fax: 734-692-1541 |
Michael J Vilag Dds Pc Clinic/Center - Dental Medicare: Not Enrolled in Medicare Practice Location: 24201 Meridian Rd, Grosse Ile, MI 48138 Phone: 734-692-0102 Fax: 734-692-1541 |
Uday Family Dentistry, Plc Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 8930 Macomb St, Grosse Ile, MI 48138 Phone: 734-676-2288 |
News Archive
BioTrove partners with FDA to investigate the utility of SNAP system
BioTrove announced a collaboration with the U.S. Food and Drug Administration's Center for Biologics Evaluation and Research to investigate the utility of the company's Standardized NanoArray PCR (SNAP) gene expression profiling system for the rapid and specific detection of pathogens in the nation's blood supply.
Younger breast cancer patients have greater chance of recurrence
Breast cancer patients 35 years old and younger have higher rates of their cancer returning after treatment than older women patients with the same stage of cancer, and their risk of recurrence is greatly impacted by the type of treatment they received, according to a March 1 study in the International Journal of Radiation Oncology*Biology*Physics, the official journal of the American Society for Radiation Oncology (ASTRO).
McKinley Infocapital to distribute Biofield Breast Diagnostic System in Korea
Biofield Corp. announced today that its 51% owned subsidiary, Sky Unicorn Holdings Ltd., has engaged McKinley Infocapital as its exclusive distributor in Korea for its flagship product, the Biofield Breast Diagnostic System (BDS). McKinley Infocapital, an international business consulting and investment management firm, has formed MacKay Life Sciences Korea to market and promote the BDS in Korea.
EpiCept increases exercise price of June 2010 Warrants to $1.64 per share
EpiCept Corporation has amended the exercise price of its Series A Warrants and Series B Warrants sold in June 2010 from $1.57 per share to $1.64 per share. The exercise price was amended by Amendment No.1 dated as of July 8, 2010, to the Securities Purchase Agreement between EpiCept and each of the purchasers signatory thereto, which amended the Securities Purchase Agreement dated June 25, 2010 between EpiCept and each of the purchasers signatory thereto.
Hospitalization rates in NYC for patients with CA-MRSA more than tripled between 1997-2006
Hospitalization rates in New York City for patients with community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA), a potentially deadly bacterial infection that is resistant to antibiotic treatment, more than tripled between 1997 and 2006, according to a report published in the July issue of Infection Control and Hospital Epidemiology, the journal of the Society for Healthcare Epidemiology of America.
› Verified 9 days ago